Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2020-01-16 2018-08-11
Drug Identification Number 02409968 02409968
Brand name CEFTRIAXONE FOR INJECTION CEFTRIAXONE FOR INJECTION
Common or Proper name CefTRIAXone for Injection CefTRIAXone for Injection
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients CEFTRIAXONE CEFTRIAXONE
Strength(s) 100G 100G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100g SmartPak 100g SmartPak
ATC code J01DD J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-07-13 2018-07-13
Actual start date
Estimated end date Unknown 2018-10-31
Actual end date 2018-11-14
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments If you have any questions or concerns, please do not hesitate to contact customer service at (877) 821-7724.
Health Canada comments